Related Experiment Videos
Neurofibromatosis type 1: brain stem tumours
L T Bilaniuk1, P T Molloy, R A Zimmerman
1Department of Radiology, Children's Hospital of Philadelphia, Pennsylvania 19104, USA.
Neuroradiology
|October 23, 1997
Summary
Neurofibromatosis type 1 (NF1) patients with brain stem tumors often present with medullary enlargement. Diffuse tumors in NF1 patients show a better prognosis than similar tumors in non-NF1 individuals.
Area of Science:
- Neurology
- Oncology
- Genetics
Background:
- Neurofibromatosis type 1 (NF1) is a genetic disorder associated with various tumors.
- Brain stem tumors are a known complication, but their characteristics in NF1 patients require further elucidation.
Purpose of the Study:
- To detail the clinical and imaging findings of brain stem tumors in patients with NF1.
- To compare the behavior and prognosis of brain stem tumors in NF1 patients versus the general population.
Main Methods:
- Retrospective review of 25 NF1 patients diagnosed with brain stem tumors between 1984 and 1996.
- Analysis of clinical, radiological, and pathological data from patient records and imaging.
Main Results:
- Brain stem tumor diagnosis often occurred years after NF1 diagnosis.
- Medullary enlargement was the most common finding (68%), followed by pontine (52%) and midbrain (44%).
- Diffuse tumors required hydrocephalus treatment more frequently (67%) than focal tumors (15%).
- Fibrillary astrocytomas were identified surgically; one progressed to anaplastic astrocytoma.
- 40% of patients had concurrent optic pathway tumors.
- Diffuse brain stem tumors in NF1 patients demonstrated a more favorable prognosis compared to non-NF1 patients.
Conclusions:
- Brain stem tumors in NF1 patients exhibit distinct imaging and clinical features.
- Diffuse brain stem tumors in NF1 patients appear to have a better prognosis than in the general population, warranting further investigation into their biological behavior.